Siddharth Kunte

1 Patent

• US125783382026

  Radiomic Heterogeneity as Prognostic Predictor for Treatment with CDK 4/6 Inhibitors in Hormone Receptor-positive Metastatic Breast Cancer

  UH Cleveland Medical Center

  0 cites